| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 07/29/2009 | EP2081892A1 Compounds and methods for treating protein folding disorders |
| 07/29/2009 | EP2081572A1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group |
| 07/29/2009 | EP1807407B1 Aromatic amides as inhibitors of c-fms kinase |
| 07/29/2009 | EP1701944B1 2-(amino-substituted)-4-aryl pyramidines and related compounds useful for treating inflammatory diseases |
| 07/29/2009 | EP1678166B1 Protein kinase inhibitors |
| 07/29/2009 | EP1513527B1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers |
| 07/29/2009 | EP1397357B1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 07/29/2009 | CN101495473A Azolylmethyloxiranes, use thereof for controlling plant pathogenic fungi, and agents containing the same |
| 07/29/2009 | CN101492444A Nitrogenous heterocyclic compounds with insecticidal activity, preparation and uses thereof |
| 07/29/2009 | CN101492416A Compounds effecting glucokinase |
| 07/29/2009 | CN101492383A Process for making chiral 1,4-disubstituted piperazines |
| 07/29/2009 | CN100519573C Novel chemical substance having morphogenetic and growth-accelerating activities |
| 07/29/2009 | CN100519556C Method of synthesizing Itraconazole |
| 07/29/2009 | CN100519550C 2-oxo-indole compound having a functtion of inhibiting glycogen synthase kinase-3 |
| 07/29/2009 | CN100519549C Pyrimidine derivatives and pharmaceutical compositions containing the compounds |
| 07/29/2009 | CN100519539C N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/29/2009 | CN100519528C Compounds with analgesic effect |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/29/2009 | CN100519526C Azabicyclo derivatives as muscarinic receptor antagonists |
| 07/28/2009 | US7566786 enzyme inhibitor 4-[(3-methylphenyl)amino]-6-(methylsulfonyl)-3-quinolinecarboxamide; antiinflammatory agents for treatment, prophylaxis of inflammatory or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, rheumatoid arthritis or allergic rhinitis |
| 07/28/2009 | US7566734 Imidazolyl derivatives |
| 07/28/2009 | US7566718 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity |
| 07/28/2009 | US7566710 4-((7-chloroquinolin-4-yl)aminoalkyleneamino-)-spiro(cyclohexane-1.5'-1H-4,5,6-trioxaindene )dicitrate; malaria; paraciticides; antiprotozoa agents; Plasmodium; synergistic; chloroquine-resistant; cost efficiency; industrial scale; penetration and activity of artemisine |
| 07/28/2009 | US7566709 4-(3-(2-Fluorophenyl)-1-phenyl-1H-pyrazol-4-ylmethyl)morpholine; 5HT2A/5HT2C receptors; central nervous system; schizophrenia; antidepressants; dementia; Parkinson's disease; Azheimer's disease; Huntington's disease; Tourette's syndrome; anxiolytic agents; congnition activators; analgesics |
| 07/28/2009 | US7566444 Versatile hydrophilic dyes |
| 07/23/2009 | WO2009091634A1 Crystalline 2-(4-cyclopropanesulphonyl-phenyl)-n-pyrazin-2-yl-3-(tetrahydropyran-4-yl)-propionamide |
| 07/23/2009 | WO2009091433A2 Spiro and dispiro 1,2,4-trioxolane antimalarials |
| 07/23/2009 | WO2009091324A1 Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents |
| 07/23/2009 | WO2009091014A1 Phenyl acetamide derivative |
| 07/23/2009 | WO2009090548A2 3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands |
| 07/23/2009 | WO2009063061A3 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 07/23/2009 | WO2009050352A3 Imidazolone derivatives, preparation method thereof and biological use of same |
| 07/23/2009 | WO2009013348A3 Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions |
| 07/23/2009 | WO2008061796A3 Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins |
| 07/23/2009 | WO2008059130A9 Thionucleosides and pharmaceutical applications |
| 07/23/2009 | US20090186932 Pesticidal N-Phenylpyrazole Derivatives |
| 07/23/2009 | US20090186927 Trans-9,10-dehydroepothilone c and d, analogs thereof and methods of making the same |
| 07/23/2009 | US20090186921 Azacyclic compounds |
| 07/23/2009 | US20090186914 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 07/23/2009 | US20090186906 N-((S)-4,4-dimethyl-1-oxo-1-((3aS,6aR)-3-oxo-dihydro-2H-furo[3,2-b]pyrrol-4(5H6H, 6aH)-yl)pentan-2-yl)-4-(4-methylpiperazin-1-yl)benzamide; treatment of a disease selected from osteoporosis, Paget's disease, Chagas's disease, malaria, gingival diseases, hypercalaemia, metabolic bone disease, bone cancer |
| 07/23/2009 | US20090186895 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 07/23/2009 | US20090186871 Tyrosine kinase inhibitors |
| 07/23/2009 | US20090186834 Diphenylheterocycle cholesterol absorption inhibitors |
| 07/23/2009 | US20090186373 Pyrimidines reacting with O6-Alkylguanine-DNA alkyltransferase |
| 07/23/2009 | CA2712948A1 Phenylacetamide derivative |
| 07/23/2009 | CA2712245A1 Crystalline (r)-2-(4-cyclopropanesulphonyl-phenyl)-n-pyrazin-2-yl-3-(tetrahydropyran-4-yl)-propionamide |
| 07/23/2009 | CA2711912A1 Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents |
| 07/22/2009 | EP2080754A2 Organic compounds |
| 07/22/2009 | EP2079732A1 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist |
| 07/22/2009 | EP2079729A1 Compounds and compositions as protein kinase inhibitors |
| 07/22/2009 | EP2079701A1 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 07/22/2009 | EP2079693A1 Ether derivatives dual modulators of the 5-ht2a and d3 receptors |
| 07/22/2009 | EP2079690A2 3-aza-bicyclo[3.1.0]hexane derivatives |
| 07/22/2009 | EP1896460B1 Benzofuranyl derivatives as 5-ht6-receptor inhibitors |
| 07/22/2009 | EP1750704B1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 07/22/2009 | EP1745039A4 3-aryl-5,6-disubstituted pyridazines |
| 07/22/2009 | EP1644337B1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 07/22/2009 | EP1503988B1 Fredericamycin derivatives |
| 07/22/2009 | EP1392680B1 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3 |
| 07/22/2009 | EP1391456B1 2-iminoimidazole derivatives |
| 07/22/2009 | CN101490043A Azolylmethyloxiranes, use thereof for controlling plant pathogenic fungi, and agents containing the same |
| 07/22/2009 | CN101490042A Fungicide hydroximoyl-tetrazole derivatives |
| 07/22/2009 | CN101486682A N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/22/2009 | CN101486675A 2- and 2,5-substituted phenylketoenols |
| 07/22/2009 | CN100515419C Substituted benzazoles and its application as inhibitors of Raf kinase |
| 07/21/2009 | US7563910 Heterocyclic cannabinoid receptor antagonists |
| 07/21/2009 | US7563907 Fluorophores with a large Stokes shift, high photostability, long storage life and a high fluorescent quantum yield, and that can be excited by white light or lasers in the ultraviolet, visible or near-infrared spectral region; immunoassays, receptor binding assays, DNA sequencing, electrophoresis |
| 07/21/2009 | US7563905 Triazole derivatives and method of using the same to treat HIV infections |
| 07/21/2009 | US7563900 Reacting 4-cyclopentyloxy-3-hydroxy-benzaldehyde with 3-bromo-4-fluoro nitrobenzene |
| 07/21/2009 | US7563811 3-(2-Cyanophenyl)-5-(2-methoxyphenyl)-1-phenyl-1,2-dihydropyridin-2-one; antagonists of AMPA and kainate receptors; neuroprotectants; neurodegenerative diseases; Alzheinmer's disease; antiepileptic agents; antispasmodic agents; anxiolytic agents; ddrug abuse; nervous sytem disorders; antihypoxic agents |
| 07/21/2009 | US7563808 administering a cholinesterase inhibitor ( a dimethoxyindanone derivative) to treat dementia associated with or caused by vascular diseases |
| 07/21/2009 | US7563784 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 07/21/2009 | CA2495943C Indoles having anti-diabetic activity |
| 07/21/2009 | CA2379972C Prodrug of an ice inhibitor |
| 07/16/2009 | WO2009089057A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 07/16/2009 | WO2009088531A1 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 07/16/2009 | WO2009088103A1 Pyridylamidine compound or salt thereof, and agricultural or horticultural fungicide composition containing the same as active ingredient |
| 07/16/2009 | WO2009088070A1 (heterocyclic methyl)azolylmethylcyclopentanol derivative and intermediate thereof, process for production of the derivative, and agricultural or horticultural preparation and protective agent for industrial material each comprising the derivative |
| 07/16/2009 | WO2009087212A2 Pyridine derivatives |
| 07/16/2009 | WO2009086835A1 Novel cyanoguanidines |
| 07/16/2009 | WO2009058800A3 Synthesis of nucleosides |
| 07/16/2009 | WO2008079787A8 Glucokinase activators |
| 07/16/2009 | US20090182150 Deblocking, deprotecting via hydrogenation |
| 07/16/2009 | US20090182149 Salt of sulfinylbenzimidazole compound, and crystal and amorphous form thereof |
| 07/16/2009 | US20090182143 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 07/16/2009 | US20090182140 Alicyclic Heterocyclic Compound |
| 07/16/2009 | US20090182028 Plant Components and Extracts and Uses Thereof |
| 07/16/2009 | US20090182011 Chimeric Nitrate Esters and Use of the Same in a Treatment for Depression |
| 07/16/2009 | US20090182007 Organic compounds |
| 07/16/2009 | US20090181994 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 07/16/2009 | US20090181993 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 07/16/2009 | US20090181981 Crystalline (r)-2-(4-cyclopropanesulphonyl-phenyl)-n-pyrazin-2-yl-3-(tetrahydropyran-4-yl)-propionamide |
| 07/16/2009 | US20090181979 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
| 07/16/2009 | US20090181968 Novel 3-Bicyclocarbonylaminopyridine-2-Carboxamides or 3-Bicyclocarbonylaminopyrazine-2-Carboxamides |
| 07/16/2009 | US20090181966 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 07/16/2009 | US20090181958 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions |
| 07/16/2009 | US20090181949 1h-imidazole derivative having cb1, agonistic, cb1 partial agonistic or cb1 antagnistic activity |
| 07/16/2009 | US20090181939 Azetidinecarboxamide Derivatives And Their Use In The Treatment Of CB1 Receptor Mediated Disorders |
| 07/16/2009 | CA2711815A1 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 07/16/2009 | CA2711803A1 Pyridine derivatives |